Amer Al Saif1, Samira Al Senany2. 1. Department of Physical Therapy, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. 2. Department of Public Health, Faculty of Nursing, King Abdulaziz University: P.O. Box 22246, Jeddah 4929, Saudi Arabia.
Abstract
[Purpose] The purpose of this study was to determine the validity, demographic features of the newly developed Amer Dizziness Diagnostic Scale (ADDS), provide differential diagnosis of the vestibular disorders, assist in the clinical research and practice activities of health workers as well as to understand the probability of the utilization of the ADDS as a first-line evaluation tool in general clinical practice. [Subjects and Methods] Two hundred subjects of various ages including both male and female patients with a history of vertigo and/or dizziness were included in the study and evaluated once using the ADDS. [Results] There were more female (59.5%) than male (49.5) patients in this study. Additionally, we found that most patients (64.4%) had a central mediated problem. In addition, the Amer Dizziness Diagnostic Scale has been found to have both a sensitivity and specificity of 96% that can adequately determine the possible diagnosis of vestibular disorders. [Conclusion] This study has demonstrated the validity of the ADDS scale, the predominance of female involvement related to supplementary medication, vitamin D deficiency, general lifestyle factors, and fluid retention, high sensitivity and specificity, provide differential diagnosis of vestibular disorders that could be used as a first-line evaluation tool in general clinics.
[Purpose] The purpose of this study was to determine the validity, demographic features of the newly developed Amer Dizziness Diagnostic Scale (ADDS), provide differential diagnosis of the vestibular disorders, assist in the clinical research and practice activities of health workers as well as to understand the probability of the utilization of the ADDS as a first-line evaluation tool in general clinical practice. [Subjects and Methods] Two hundred subjects of various ages including both male and female patients with a history of vertigo and/or dizziness were included in the study and evaluated once using the ADDS. [Results] There were more female (59.5%) than male (49.5) patients in this study. Additionally, we found that most patients (64.4%) had a central mediated problem. In addition, the Amer Dizziness Diagnostic Scale has been found to have both a sensitivity and specificity of 96% that can adequately determine the possible diagnosis of vestibular disorders. [Conclusion] This study has demonstrated the validity of the ADDS scale, the predominance of female involvement related to supplementary medication, vitamin D deficiency, general lifestyle factors, and fluid retention, high sensitivity and specificity, provide differential diagnosis of vestibular disorders that could be used as a first-line evaluation tool in general clinics.
Dizziness is one of the most common symptoms that prompt clinical consultation. Although
the sensation of imbalance is a common symptom1,2,3,4), it may indicate a serious condition. There
are four types of dizziness. Described as the sensation of ground instability, vertigo is
often accompanied by nausea, vomiting, and the inability to maintain balance, which can
cause limit the ability to stand or walk5,6,7).
Lightheadedness refers to the feeling of faintness and weightlessness8). Disequilibrium is the impaired sense of equilibrioception
such that confident ambulation is impaired while presyncope is described as the sudden loss
of consciousness associated with cardiovascular disorders as orthostatic hypotension9,10,11).In general, the most common cause of vertigo is benign paroxysmal positional vertigo
(BPPV)12, 13). Lightheadedness occurs with hyperventilation. Disequilibrium may
be due to Multiple Sensory Deficit Syndrome while orthostatic hypotension can lead to
presyncope. The 4th national morbidity survey estimates the worldwide rate and prevalence of
dizziness as 93 per 10,000 people per years at risk. More specifically, in the United States
(US), the annual incidence in primary care was 1.7%, while outpatient recorded a higher
percentage of 17% with a whole person lifetime risk of 25%. In contrast, the United Kingdom
(UK) demonstrated a 40% incidence rate14).
In rural areas, the ratio was 1:4 for those between 50–65 years of age, while London
recorded a 20% risk with younger age (25–64 years old)15). Currently, with the evolution of advances in technology, a wide
range of laboratory tests is available for the evaluation of the vestibular and balance
systems along with the clinical history. These include video nystagmography (VNG) recording
for eye examinations, caloric and rotary chair testing as well as electronystagmography
(ENG)16,17,18). Traditionally,
electronystagmography has been considered as the “gold standard‟ for evaluating
dizziness.A simple scale called the Amer Dizziness Diagnostic Scale (ADDS) can be used for screening
and diagnosis at the first clinical visit in order to guide patients toward the appropriate
investigative procedures and management. It is especially useful for initial evaluation in
general primary care clinics and for referral of patients who complain of dizziness to the
appropriate medical specialist for further diagnosis and management. The scale has been
found to have both a sensitivity and specificity of 96% for the diagnosis of patients with
vestibular disorders. During the last several years, Saudi Arabia has undergone a massive
improvement in the standard of living resulting in major changes in physical activity and
eating habits. Low levels of physical fitness and an increasingly sedentary lifestyle are
becoming more common in Saudi society19)
increasing the risk for lifestyle-related diseases including cardiovascular (i.e., coronary
artery disease) and respiratory diseases, diabetes, anxiety, depression, and obesity20, 21).Vitamin D plays an important role in maintaining bone structure and low levels result in
osteoporosis, osteomalacia, and other bone diseases. Slight decreases in vitamin D levels
can result in increased bone resorption and secondary hyperparathyroidism22). Regarding the significant role of
sunlight in vitamin D production, it is hypothesized that vitamin D deficiency is more
widespread in countries that do not have tropical climates. However, studies in the past two
decades have demonstrated an increased prevalence of vitamin D deficiency in tropical
countries, including Saudi Arabia by 30% and 93%23). Additionally, the increased use of the electronic systems (i.e.,
computers, television) and communication technologies will decrease physical activity in the
coming years resulting in considerable health effects. This may cause an epidemic of
non-communicable diseases along with their complications in the region24).This study was performed in order to examine the validity, demographic features of the
newly developed Amer Dizziness Diagnostic Scale (ADDS), provide differential diagnoses of
vestibular disorders and assist in clinical research activities and practice of health
workers. This study was also performed in order to understand the possibility of the
increased utilization of ADDS as a first-line evaluation tool in general medical clinics so
each member of the health care team can effectively screen patients who complain of
dizziness and refer them to the appropriate specialist for diagnosis, consultation, and
management. Since dizziness is multi-factorial disease and a global problem that is related
to the level of physical activity and poor general lifestyle1,2,3,4).
SUBJECTS AND METHODS
Two hundred subjects from the Kingdom of Saudi Arabia who were of various ages, and
included both male and female patients with a history of dizziness and/or vertigo, were
enrolled in this study. The Institutional Review Board of the King Abdulaziz University
approved this study. Otolaryngologists, neurologists, or family physicians in and around
Jeddah referred all subjects for participation. After explaining the need for the study to
potential subjects, informed consent and participation was obtained for this study. In order
to evaluate the patients, we administered the Amer Dizziness Diagnostic Scale (ADDS) as a
structured interview where participants were asked seventeen specific questions that cover
different aspects of dizziness or vertigo, such as the type of dizziness, symptoms, tempo,
circumstances, history etc. The questions in the scale were arranged as a hierarchical
decision tree and each question was aimed at one behavior and required a “yes” or “no”
answer. The presence and severity of the dizziness symptoms were rated on a scale based on
the category or section. Thus, possible scores varied from 0 to 113, with each category of
scores indicating a different diagnosis. The 17 questions in the ADDS were arranged into
five categories. The first category included general information about the patients gender,
age as well as a history of hypertension, diabetes mellitus, balance problems, partial
hearing loss associated with dizziness, and symptoms of blurred or double vision that
results in vomiting. The second category was specific to the Unilateral Vestibular
Hypo-function (UVH), and included a diagnosis of a viral or bacterial infection in the last
two weeks, a history of blurred vision with or without vomiting and information on whether
they drifted to one side when walking. The third category has a critical value for Benign
Paroxysmal Positional Vertigo (BPPV), and includes questions about the sensation of
dizziness while moving the head and with different body movements. The fourth category is
related to the Central Mediated Problem (CM), and included information on the previous
diagnosis of any neurological disorders, a history of concussions before experiencing
dizziness, the sensation of lightheadedness or fainting while moving from the sitting to
standing position and the presence of tinnitus. The fifth category, which relates to all
previous vestibular disorders and to Cervicogenic Dizziness (CGD), focuses on the episodes
of dizziness. Questions 1 to 16 were designed to be answerable with a “yes” or “no”, and
question 17 was designated only for dizziness episodes. For each of the 17 questions, a “no”
answer was always equivalent to 0. The first category did not have any score, while one
point was given for every “yes” answer in the second category. For every “yes” answer, 5 and
20 points were given in the 3rd and 4th category, respectively. For the final category, if
the dizziness lasted only seconds 1 point was given. If it lasted for minutes or hours, 5
and 20 points were given, respectively. If the total ADDS score was 0, a CGD was the most
likely diagnosis. If the total score was between 1 and 4, the patient was diagnosed with
UVH. Scores that were between 5 and 19 indicated Benign Paroxysmal Positional Vertigo
(BPPV), while scores of 20 or higher, indicated the CM pathology. The scale was designed to
establish the exact pathology so the patient can be directed to the specific diagnosis and
the required treatment. The scale is of benefit for both clinicians and patients, because it
is efficient and prevents unwanted and expensive diagnostic procedures. Participants were
first evaluated using the ADDS before routine tests, audiometry, and neurological exams, as
well as tests of VOR function for establishing any vestibular deficit, are performed. In
order to measure the sensitivity and specificity, as well as the “true-positive” or
“true-negative” responses; the results of both tests were then compared statistically to
establish the correlation, sensitivity, and specificity of the scale.
RESULTS
The results were analyzed using the SPSS statistical package for Windows version 19.0
(SPSS, Inc., Chicago, IL, USA). The results of the statistical analysis as well as the
characteristics of the 205 subjects who participated in this study are presented in Table 1. By using the Amer Dizziness Diagnostic Scale (ADDS), which utilizes clear and
simple questions that are easy to understand, patients were directed toward the expected
diagnosis. The comprehensive questions utilized appropriate language and length without any
biases in the responses since these have been previously examined and approved by the
experts.
Table 1.
Baseline clinical characteristics of patients with vestibular disorders
Age (y), n (%)
Below 55 years
190 (92.7%)
Above 55 years
15 (7.3%)
Gender, n (%)
Male
83 (40.5%)
Female
122 (59.5%)
Diagnosis (Gold Standard)
BPPV
34 (16.6%)
UVH
11 (4.5%)
CGD
28 (13.7%)
CM
132 (64.4%)
The results demonstrated the strong correlation between the ADDS and the “true-positive”
and “true-negative” results (r = 0.95, p < 0.05). A stepwise linear regression was
performed and the results indicated that ADDS was a significant predictor of “true-positive”
and “true-negative” results (R2 = 0.90, p < 0.05). Approximately 90% of the
variability in “true-positive” and “true-negative” results were explained by their
relationship to the ADDS. Based on the ADDS, there were 34 (16.6%), 11 (5.4%), 28 (13.7%),
and 132 (64.4%) patients with BPPV, UVH, CGD, and CM, respectively, in this study. There
were also more female (59.5%) than male (49.5%) patients in this study. Additionally, CM was
diagnosed most frequently (64.4%) compared to the other types of dizziness. The ADDS was
found to have both a sensitivity and specificity of 96% and can adequately capture a
possible diagnosis of vestibular disorders.
DISCUSSION
The current study aimed to determine the validity of the newly developed Amer Dizziness
Diagnostic Scale (ADDS), provide the differential diagnosis of vestibular disorders, assist
in clinical research and practice, determine the possibility of utilizing the ADDS as a
first-line evaluation tool in general clinical practice so each health care member can
effectively screen patients with dizziness and refer them to the appropriate medical
specialist for diagnosis, consultation, and management.A multi-factorial disease, dizziness is one of the most common symptoms that prompt
clinical consultation. Although the sensation of imbalance is a common symptom1,2,3,4), it
may indicate a serious condition. Typically, dizziness is divided into four
subtypes—vertigo, lightheadedness, disequilibrium, and oscillopsia. This classification is
still the basic definition of dizziness2, 3). The ADDS consists of questions that provide
the possible diagnosis and reasons for dizziness at baseline. Additionally, this scale may
be useful in clinical research studies and practice as a first-line evaluation tool for
dizziness. There are many scales that are used for patients who have already been diagnosed
with ADDS, including the Dizziness Handicap Inventory (DHI) and the VSS-VER in order to
establish the severity of dizziness and its clinical impact. The ADDS was utilized in this
study as the basis for the differential diagnosis, examination, and treatment of dizziness
as it functions as a relevant tool as well as a reliable reference guide for all healthcare
workers. Many clinicians have difficulty reaching the most accurate diagnosis even if they
take a comprehensive history, since there is no valid diagnostic scale for dizziness. This
study indicates that because the specificity and sensitivity of the ADDS for distinguishing
between different vestibular disorders is high, it helps the inexperienced or general
medicine physician to detect any patient with dizziness and facilitate the referral process.
The next goal is to upgrade this scale by using different languages in order for this
application to be used more globally and to assess more demands, social activities,
establishing the reliability and discriminate validity of the ADDS. The primary benefit of
this scale lies in its ability to provide a direct comparison between population and studies
among different countries. The current study reveals that ADDS is the best tool for this
role, since it has a close relationship with the measure of Vestibular Disorders. The ADDS
consists of 17 questions that is arranged according five categories. The first category is
general information about the patients that are intended for statistical and research
purposes. The second category is specific to UVH especially with the characteristic symptom
of drifting towards the same side while walking, a classical finding in UVH. The third
category has a critical value for BPPV, where all questions are related to dizziness while
moving the head and with different body movements3,
4). The fourth category is related to the
CM, which seeks to understand the role of the various clinical specialties in the further
evaluation of symptoms, such that if diagnosed with Central Mediated the patient must be
referred to the neurology clinic for consultation. The fifth category related to the CGD, is
a diagnosis of exclusion. And at the end of the evaluation, the clinician must be able to
diagnose the exact pathology and direct patients toward the required treatment. The results
demonstrated higher proportion of female (59.5%) compared to male (49.5%) participants,
which is usually related to the administration of the supplementary medication, vitamin D
deficiency, general lifestyle and fluid retention. The differential diagnoses of central
vestibular problems include stroke or tumor in the brain, migraine, Meniere’s disease,
Pre-lymphatic fistula, and head trauma, based on the previous study entitled “Peripheral
versus Central Vestibular Disorders.” According to studies, most cases (64.4%) involved the
central vestibular system. This is because patients initially arrive with symptoms of
central vestibular problems, which later converted to one of the other type of dizziness
(i.e., UVH) due to accumulation of fluid in the inner ear24,25,26).This scale shortens the long and expensive process for the patient and clinicians. In order
to evaluate the sensitivity and specificity of the scale, we compared it to the standard
routine testing of clinical signs and symptoms, audiometry, and neurological examination,
along with tests of VOR function, which often serve as the “gold standard” for determining
the probability of a vestibular deficit.